Zelluna ASA (OSTO:ULTIO) Other Current Liabilities : kr25.75 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Zelluna ASA Other Current Liabilities?

Zelluna ASA's other current liabilities for the quarter that ended in Mar. 2025 was kr25.75 Mil.

Zelluna ASA's quarterly other current liabilities increased from Sep. 2024 (kr3.76 Mil) to Dec. 2024 (kr18.56 Mil) and increased from Dec. 2024 (kr18.56 Mil) to Mar. 2025 (kr25.75 Mil).

Zelluna ASA's annual other current liabilities declined from Dec. 2022 (kr13.97 Mil) to Dec. 2023 (kr12.66 Mil) but then increased from Dec. 2023 (kr12.66 Mil) to Dec. 2024 (kr18.56 Mil).

Zelluna ASA Other Current Liabilities Historical Data

The historical data trend for Zelluna ASA's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelluna ASA Other Current Liabilities Chart

Zelluna ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Liabilities

Get a 7-Day Free Trial

7.11

7.03

13.97

12.66

18.56

Zelluna ASA Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Liabilities	Get a 7-Day Free Trial															17.15	12.21	3.76	18.56	25.75

Zelluna ASA Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Zelluna ASA Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Zelluna ASA's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zelluna ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (OSTO:ULTIo) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

ZLNA:Norway 7UM0:Germany

Address

Ullernchausseen 64, Oslo, NOR, 0379

Website

https://www.zelluna.com

Zelluna ASA is a clinical-stage biotechnology company developing novel immunotherapies against cancer and the development of T-Cell Receptor Natural Killer cell therapies for the treatment of solid cancers. The company's current pipeline consists of allogeneic TCR-NK R&D programs ZI-MA4-1, ZI-KL1-1, and ZI-PR-1 targeting well validated antigens expressed across a broad range of solid tumors.

Zelluna ASA Headlines

No Headlines